# Cambridge Liquid Biopsy and Tumour Profiling Study for Patients on Experimental Therapeutics Trials

> **NCT02994511** · — · UNKNOWN · sponsor: **CCTU- Cancer Theme** · enrollment: 100 (estimated)

## Conditions studied

- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02994511
- **Lead sponsor:** CCTU- Cancer Theme
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-12-08
- **Primary completion:** 2020-03-30
- **Final completion:** 2020-03-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02994511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02994511, "Cambridge Liquid Biopsy and Tumour Profiling Study for Patients on Experimental Therapeutics Trials". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02994511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*